Details:

Alternative Title:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control
Corporate Authors:
Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; National Center for Infectious Diseases (U.S.) ; National Center for Infectious Diseases (U.S.) ;
Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; National Center for Infectious Diseases (U.S.) ; National Center for Infectious Diseases (U.S.) ; Less -
Description:
These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1992-1993 influenza season (superseding the MMWR 1991; 40(no. RR-6): 1-15.) The primary changes include statements about vaccination of persons with known hypersensitivity to eggs or other components of the influenza vaccine, the optimal timing of influenza vaccination, and the influenza strains in the trivalent vaccine for 1992-1993.
Subject:
[+]
Adolescent
Adult
Aged
Amantadine
Child
Child, Preschool
Drug Hypersensitivity
Female
Humans
Infant
Influenza, Human
Influenza A Virus
Influenza B Virus
Influenza Vaccines
Pregnancy
Risk Factors
Vaccination

Source:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1992 ; 41(RR-9):1-17.;
Document Type:
Journal Issue ;
Name as Subject:
Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.) ;
Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.) ; Less -
Place as Subject:
United States ;
Collection(s):
Guidelines and Recommendations
Advisory Committee on Immunization Practices (ACIP)
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:5ecc51af26e6c91895aac90208ae3b81498248403bab8dc40d30e9ee44ddbb38
File Type:

Supporting Files

• No Additional Files

More +